SUBSCRIBE

CATEGORIES

J&J Gains As Vaccine Shows Promise Against Delta Variant

imageStock Markets57 minutes ago (Jul 02, 2021 06:55AM ET)

(C) Reuters

By Dhirendra Tripathi

Investing.com – Johnson & Johnson (NYSE:JNJ) stock was trading higher during Friday’s premarket trading as findings from a small lab study indicated that the company’s single dose COVID-19 vaccine may be effective against the Delta variant of the coronavirus.

In laboratory testing, the vaccine triggered a strong immune response in blood samples taken from eight vaccinated people, J&J said Thursday. The company released the high-level findings through a press release, not a detailed peer-reviewed study.

After the virus originated in China in 2019 and spread to other countries, it has mutated several times. Delta is a variant that first emerged late last year or early 2021 in India and is now the most prevalent and also the deadliest virus in most countries.

All vaccines in the market including those from J&J, Pfizer (NYSE:PFE)-BioNTech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA), Gamaleya and Sinovac have been developed based on the original virus.

Vaccines that show a high degree of effectiveness against mutations of the virus – of which many will surely follow – have a batter chance of gaining market share as the world prepares for a long campaign against Covid-19.

J&J Gains As Vaccine Shows Promise Against Delta Variant

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.